The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / ACR Convergence

ACR Convergence

Get complete coverage of the all-virtual ACR Convergence 2021 experience here. Plus, explore our gout, rheumatoid arthritis and systemic lupus erythematosus Resource Centers for research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions.

Resource Centers

  • Systemic Lupus Erythematosus Resource Center

    Watch this space for our coverage of systemic lupus erythematosus (SLE) sessions at ACR Convergence 2021, including the top research presented at the meeting and much more.

    [View]
  • Rheumatoid Arthritis Resource Center

    In this resource center, you’ll find coverage of the new guideline for the management of rheumatoid arthritis (RA), highlights from important sessions at ACR Convergence and much more.

    [View]
  • Gout Resource Center

    Explore our coverage of the top research and additional gout information presented at ACR Convergence 2021 and much more.

    [View]

Previous ACR Meetings

  • ACR Convergence 2020
  • 2019 ACR/ARP Annual Meeting
  • 2018 ACR/ARHP Annual Meeting
  • 2017 ACR/ARHP Annual Meeting
  • 2016 ACR/ARHP Annual Meeting
  • 2015 ACR/ARHP Annual Meeting
  • 2014 ACR/ARHP Annual Meeting
  • 2011 ACR/ARHP Annual Meeting
  • 2010 ACR/ARHP Annual Scientific Meeting
  • 2006 ACR Annual Meeting
  • ACR/ARHP Annual Meeting
  • Annual Meeting

Complete Coverage

Medication Preferences & Current Practices for PsA

With many new agents designed to treat PsA, rheumatologists and patients have options. Schwartzman et al. examined the real-world use of different treatments and ranked patient medication preferences.... [Read More]

Anifrolumab Promising for Sustained Low Disease Activity in Patients with Lupus

ACR CONVERGENCE 2021—Using pooled data from the TULIP-1 and TULIP-2 clinical trials, researchers set out to identify whether more patients with systemic lupus erythematosus (SLE) being treated with anifrolumab achieved a low disease activity state than patients with SLE who received placebo.1-3 An analysis of the data was presented at ACR Convergence 2021 by Eric… [Read More]

Pre-Eclampsia Risk & Rheumatic Disease

Secher et al. evaluated the risk of pre-eclampsia in pregnant patients with RA, axSpA or PsA, assessing the effect of disease activity and disease-modifying anti-rheumatic drugs on this risk.... [Read More]

Improving Bone Mineral Density: Risedronate vs. Denosumab

Treatment with denosumab for patients with RA and glucocorticoid-induced osteoporosis led to greater increases in bone mineral density of the lumbar spine and hips of patients than treatment with risedronate.... [Read More]

Diet & Gout Research Presented at ACR Convergence 2021

According to research from Yokose et al. presented at ACR Convergence 2021, regardless of genetic predisposition, diet influences a person’s risk of developing gout. Several recent analyses of the Global Burden of Disease (GBD) Study report a disproportionate worsening of gout burden among women, suggesting intensive dietary measures for gout prevention are indicated, especially in… [Read More]

Highlights from ACR Convergence’s Late-Breaking Abstracts

COVID-19 vaccination, treatments for rheumatic disease and more—the Late-Breaking Abstracts session of ACR Convergence 2021 highlighted six studies with implications for rheumatology.... [Read More]

How to Differentiate Between & Manage Hypereosinophilic Syndromes & EGPA

Hypereosinophilic syndromes and eosinophilic granulomatosis with polyangiitis (EGPA) represent a spectrum of eosinophilic disorders. Amy D. Klion, MD, provided a detailed overview of this spectrum during ACR Convergence 2021.... [Read More]

Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

Lung disease is common, variable and frequently underdiagnosed in patients with Sjögren’s syndrome. An expert pulmonologist and a rheumatologist discussed the diagnosis and management of pulmonary manifestations of Sjögren’s syndrome during ACR Convergence 2021.... [Read More]

How Do Axial SpA & PsA with Axial Involvement Differ?

The differences between axial spondyloarthropathy (axSpA) and axial involvement in psoriatic arthritis (axPsA) have clinical and therapeutic implications. Three experts discussed the distinctions during ACR Convergence 2021. ... [Read More]

New Data Highlight Effectiveness of Guselkumab for Patients with PsA

The use of guselkumab improved joint and skin symptoms in biologic naive patients with PsA, according to research presented during ACR Convergence 2021.... [Read More]

  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)